-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
CASI Pharmaceuticals, Inc (DE) annual/quarterly Amortization of Intangible Assets history and growth rate from Q1 2017 to Q1 2022.
- CASI Pharmaceuticals, Inc (DE) Amortization of Intangible Assets for the quarter ending March 31, 2022 was $341K, a 1.19% increase year-over-year.
- CASI Pharmaceuticals, Inc (DE) annual Amortization of Intangible Assets for 2022 was $1.21M, a 10.1% decline from 2021.
- CASI Pharmaceuticals, Inc (DE) annual Amortization of Intangible Assets for 2021 was $1.35M, a 4.5% increase from 2020.
- CASI Pharmaceuticals, Inc (DE) annual Amortization of Intangible Assets for 2020 was $1.29M, a 16.8% decline from 2019.
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)